Skip to main content

Aditxt, Inc.

ADTX
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001726711

No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Aditxt, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ADTX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders14140
Shares48.0K58.9K+10.9K (+22.6%)
Value$35.9K$48.4K+$12.6K (+35.0%)

New holders (6)

Institutions that held Aditxt, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ADTX in Q4 2025
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP16,079$13.4K0.00%
HRT Financial LP15,904$13.0K0.00%
Jane Street Group, LLC12,844$10.7K0.00%
Flow Traders U.S. LLC12,453$10.0K0.00%
Danske Bank A/S2$20.00%
FMR LLC1$10.00%

Sold out (6)

Institutions that held Aditxt, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of ADTX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Virtu Financial LLC16,225$12.0K
Geode Capital Management, LLC14,350$10.8K
Two Sigma Securities, LLC10,982$8.26K
Citigroup Inc1,645$1.24K
SBI Securities Co., Ltd.87$65
TD Waterhouse Canada Inc.1$1